Upload
isha
View
31
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Tumour Working Group and Cancer Clinical Leads Forum. Monday 3 rd December 2012. Welcome and Introduction. Prof Arnie Purushotham , LCA Joint Interim Clinical Director Welcome Outline the purpose of the event Housekeeping. Clinical Leadership within the LCA. - PowerPoint PPT Presentation
Citation preview
Tumour Working Group and Cancer Clinical Leads Forum
Monday 3rd December 2012
The London Cancer Alliance West and South2
Welcome and Introduction
Prof Arnie Purushotham, LCA Joint Interim Clinical Director
– Welcome
– Outline the purpose of the event
– Housekeeping
The London Cancer Alliance West and South3
Clinical Leadership within the LCA
–Appointment process for Clinical Director and Associate Clinical Director – interviews 11th December 2012 –Appointment process for Pathway Group Chairs
– 12 Pathway Groups (tumour specific only)– Covering letter, advert, job description and job specification
emailed to CEOs, Medical Directors, Cancer Clinical Leads and Cancer Nurse Leads
– Applicants to send a covering letter and CV emailed to Claire Dowling LCA Programme Director
– Closing date for applications by 12 noon 24th December 2012
– Interviews to be held week commencing 21st & 28th January 2013
– Interview panel to include Clinical Director, Associate Clinical Director, Programme Director and Cancer Unit representative from the Interim Clinical Board
–Questions?
The London Cancer Alliance West and South4
LCA Progress to date– Establishment of the Members Board and appointment of the
Independent Chairs for the Members Board and Clinical Board
– Progress against the Clinical Plan – 1st Wave responses to the MoC– Pan London agreement on best practice commissioning
pathways in colorectal, lung, brain/CNS and breast – LCA wide best practice clinical guidelines in Breast, OG,
Lung, AOS, Survivorship & Palliative Care either agreed or in final version ready for implementation January 2013
– Leading voice in pan London informatics agenda driving progress in completeness of staging, SACT, TCR, agreement of commissioning metrics and development of LCA scorecards
– Macmillan project progress on Patient Experience, Patient Information, Chemotherapy closer to Home & Survivorship
The London Cancer Alliance West and South5
LCA Progress to date
– Emergency presentation audit underway– Improved engagement and communication
including the final stages of development of the LCA website, stakeholder engagement forums across the pathway groups, AOS simulation courses
– Development of the User Partnership agenda across London
– Development of new systems and processes for Peer Review and the wider quality agenda
The London Cancer Alliance West and South6
But there is much more to do……..– Appointment of Clinical Director & Associate Clinical Director– Establishment of remaining pathway groups and appointment
of tumour-specific Pathway Group Chairs– Delivery of the MoC recommendations in all pathway groups– Promoting prevention and early detection of cancer by
supporting GPs and public health messages– Development of the early diagnosis agenda & LCA endoscopy– Delivery of significant improvement in patient experience and
patient information across all pathway groups– Development and delivery of the LCA Medicines and
Chemotherapy agenda including chemotherapy closer to home– Mental Health and Psychological medicine– LCA Cancer research and training agenda– Engagement with the CCGs– Development and implementation of a communications
strategy – Improved collaborative working across south and west London
Commissioning and strategic priorities
Dr Kate Haire, LCA Clinical Commissioning
The London Cancer Alliance West and South
Cancer Commissioning Teams and London Cancer Programme governance structure
Operating structure from 1 April 2013
The London Cancer Alliance West and South
Commissioning of cancer services
London Cancer Programme: Strategic Themes– Improving Early Detection– Delivering care closer to home– Consistency of care – Consolidation of services– Delivering productivity and efficiency
Model of Care for Cancer Services (NHS London 2010)
The London Cancer Alliance West and South10
LCA Strategic Priorities– Work with London Cancer Programmes to develop 3 year
plan for delivery of Model of Care
– LCA Clinical Service Plan
– LCA Strategic Priorities: Pathway specific and cross cutting priorities
– Key issues• Flexibility to take account of emerging priorities• Work of London Cancer Integrated Cancer System• Commissioning arrangements from 2013• Resources• Wider political context
Preparation for Peer ReviewMr Nick Hyde, Cancer Director St George’s Healthcare NHS Trust
The London Cancer Alliance West and South12
LCA Peer Review Progress– Transition of the SE, SW & NW Cancer Network
provider functions to the LCA– Mapping of current peer review measures across
to LCA structures and processes– LCA Peer Review Transition Plan in final draft– Network Board measures transfer to Joint
Development Group due to composition and function of JDG
– Existing TWG arrangements remain in place with accountability to the Pathway groups and Clinical Board
– Approach maintains oversight & guidance to MDTs until 31st March; assurance to peer review
The London Cancer Alliance West and South13
Joint Development Group (JDG)
LCA Members Board (MB)
LCA Clinical Board (CB)
Pathway Groups (PGs)
Original 3 Tumour Working Groups
(TWGs) remain in place as interim solution 1st
October to 1st April 2013
Multi Disciplinary Teams (MDTs) Cross Cutting Groups and CYP
CNs : Trust Level
Cancer Network Board (1A)
Network Site Specific Groups / Tumour Working
Groups (NSSG / TWG) (1C)
Multi Disciplinary Teams (MDTs) (2B-M)
Current Configuration
Children’s Cancer Network Commissioning Function
(8A)
Local Area Team (LAT) or NHS Commissioning
Board
Network Cross Cutting Groups (1E)
Children and Young People (7A)
LCA Research Board
Localities (1D)
Cross Cutting Groups (3R-Z)
PCTs Chemotherapy - Community (6A adults
and Children)
Local Trust Level / CCG / Local
Borough Teams
Cancer Research Network (5A)
Proposed Transitionary Configuration
Children’s CN and TYA CN (7B, C, D)
The London Cancer Alliance West and South14
LCA Peer Review Progress– From April 1st TWG meetings will be replaced with
Pathway Group led quarterly tumour specific clinical forums – ensures compliance to 1c measures
– These quarterly forums will ensure clinical governance is at the heart of the LCA and will facilitate - clinical audit/clinical effectiveness- patient safety/ patient experience- clinical research- training and education- user involvement and service improvement- vertical communication
The London Cancer Alliance West and South15
LCA Peer Review 2013/14
– Collaborative partnership working with NCAT– Development of a “Skinny” Peer Review–
essential components to assure quality standards, systems and processes across the LCA
– Development of a Pathway Group Constitution to include:
- operational policy- an annual report- work plan
– Any Questions?
NCAT Plans and LegacyMs Ruth Bridgeman, National Programme Director, Peer Review
The London Cancer Alliance West and South
New Improvement Body (nIB)
• Will bring together several legacy organisations – NHS Institute – NHS Improvement – National Cancer Action Team – End of Life Care Programme – NHS Diabetes and Kidney – National Technology Adoption Centre
• Work programme will be based around priorities identified by the 5 Domain Directors
• Julian Hartley appointed as Interim Managing Director
The London Cancer Alliance West and South
Business Continuity
– Some programmes of work will transfer to the nIB– Some programmes will close because the work is
completed– Some programmes will need to continue and a
suitable host will need to be found for it i.e. National Cancer Peer Review Programme
– Some programmes will be discontinued – We need to capture the learning from all the work
we have done. – We need to ensure that the learning is passed on
to successor organisations
The London Cancer Alliance West and South
Transition Delivery Partner (TDP)
– Will be established to continue some of the work of existing programmes and to commence delivery on new areas of work
– TDP will exist for a period up to one year from April 2013 to March 2014
– Work programme will emerge from the nIB Business Plan
– It is proposed that the National Cancer Peer Review Programme will initially form part of the TDP
The London Cancer Alliance West and South
Developing the future Peer Review Programme– Greater focus on Outcomes– Using Service Profiles– Limited data available currently
– Fewer Measures – Some process measures will be required
– Minimising the evidence required– Operational Policy– Annual Report– Work Programme
– Greater Transparency of the reports– My Cancer Treatment
Change Presentation title and date in Footer dd.mm.yyyy20
The London Cancer Alliance West and South Change Presentation title and date in Footer dd.mm.yyyy21
The London Cancer Alliance West and South Change Presentation title and date in Footer dd.mm.yyyy22
The London Cancer Alliance West and South
Click here to view the full report
Peer Review – break out sessionMr Nick Hyde, Cancer Director St George’s Healthcare NHS Trust
The London Cancer Alliance West and South25
Break out session – 30 mins brainstorm15 mins feedback session
What are the essential components of Peer Review?–Innovative ways of working–What’s new that can be applied to Peer Review in 2013–Essential documentation–Essential structures, systems and processes–Essential feedback mechanisms–Assurance across 17 provider organisations
Closing Remarks
Mr Justin Vale, Joint Interim Clinical Director